Publication:
Health-related quality of life in adults with epidermolysis bullosa: a cross-sectional study in seven European countries using EQ-5D-5L.

dc.contributor.authorLinertová, Renata
dc.contributor.authorPéntek, Márta
dc.contributor.authorRodríguez-Díaz, Benjamín
dc.contributor.authorBodemer, Christine
dc.contributor.authorHübl, Vinzenz
dc.contributor.authorEl Hachem, May
dc.contributor.authorSalamon, Gudrun
dc.contributor.authorAlonso-Ferreira, Veronica
dc.contributor.authorStefanov, Georgi
dc.contributor.authorJain, Ritu
dc.contributor.authorRamallo-Fariña, Yolanda
dc.contributor.authorGarcía-Pérez, Lidia
dc.contributor.funderUnión Europea. Comisión Europea. H2020
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderDEBRA
dc.contributor.funderNational Research, Development and Innovation Office (Hungria)
dc.date.accessioned2026-11-17T13:39:16Z
dc.date.available2026-11-17T13:39:16Z
dc.date.issued2026-03-19
dc.description.abstractBackground: Epidermolysis bullosa (EB) is a rare genetic disorder that causes extreme skin fragility, chronic pain, and functional impairment, with major psychosocial and economic consequences. Health-related quality of life (HRQoL) data is critical to capture the full burden of EB. Health utilities derived from preference-based generic instruments such as the EQ-5D-5L provide standardized health status utility values that enable cross-disease comparisons and provide input data for cost-utility analyses to inform resource allocation. There is a notable lack of multinational, up-to-date utility data for EB. This cross-sectional study aimed to assess HRQoL in adults with EB across seven European countries (Austria, Bulgaria, Germany, Hungary, Italy, France, and Spain) using the EQ-5D-5L. Results: A total of 328 adults with EB participated in the survey, 61% were female, 37% were between 18 and 30 years old and 46% had dystrophic EB. Based on self-reported symptoms, 58% were classified as severe EB. Pain/discomfort was the most affected EQ-5D-5L dimension (92% reporting problems; 27% severe or extreme). The mean EQ-5D value (health utility) was 0.63 (SD 0.32), ranging from 0.57 in Spain to 0.71 in Bulgaria. Patients with severe EB reported significantly lower utilities than non-severe cases (0.52 vs. 0.78, p < 0.001). Mean EQ VAS score was 60 (SD 23.2). Compared to general population norms, EB patients in all countries had markedly lower HRQoL (p < 0.005), with large effect sizes for the EQ-5D value (Cohen's d ≥ 0.8). Symptomatic burden and functional deterioration were the primary drivers of HRQoL impairments. Conclusions: This multinational study provides the most extensive and current health utility data for adults with EB in Europe. Findings reveal the profound HRQoL impairment in EB, particularly in severe cases. These standardized utility values fill a major evidence gap, supporting their use in health economic evaluations, cross-disease comparisons, and policy development.
dc.description.peerreviewedSí
dc.description.sponsorshipThe project BUR-EB has received funding from the European Union’s Horizon 2020 research and innovation programme under the EJP RD COFUND-EJP Nº 825575. Additionally, the project has been supported by Instituto de Salud Carlos III (grant AC21_2/00011) and National Research, Development, and Innovation Fund of Hungary, financed under 2019 − 2.1.7-ERA-NET funding scheme at Obuda University; DEBRA Austria partially funded the study carried out in Austria.
dc.format.number1
dc.format.page167
dc.format.volume21
dc.identifier.citationLinertová, R., Péntek, M., Rodríguez-Díaz, B. et al. Health-related quality of life in adults with epidermolysis bullosa: a cross-sectional study in seven European countries using EQ-5D-5L. Orphanet J Rare Dis 21, 167 (2026). https://doi.org/10.1186/s13023-026-04299-1
dc.identifier.doi10.1186/s13023-026-04299-1
dc.identifier.e-issn1750-1172
dc.identifier.journalOrphanet journal of rare diseases
dc.identifier.pubmedID41857746
dc.identifier.urihttps://hdl.handle.net/20.500.12105/27837
dc.language.isoeng
dc.publisherSpringer Nature
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/825575/EU
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación/AC21_2%2F00011/ES/CAMBIOS EN LA CARGA SOCIO-ECONOMICA DE EPIDEMOLISIS BULLOSA EN EUROPA/
dc.relation.publisherversionhttps://doi.org/10.1186/s13023-026-04299-1
dc.repisalud.centroISCIII::Instituto de Investigación de Enfermedades Raras (IIER)
dc.repisalud.institucionISCIII
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectEQ-5D-5L
dc.subjectEpidermolysis bullosa
dc.subjectHealth utilities
dc.subjectHealth-related quality of life
dc.subjectPatient reported outcomes
dc.subject.meshAdolescent
dc.subject.meshAdult
dc.subject.meshCross-Sectional Studies
dc.subject.meshEpidermolysis Bullosa
dc.subject.meshEurope
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshQuality of Life
dc.subject.meshSurveys and Questionnaires
dc.subject.meshYoung Adult
dc.titleHealth-related quality of life in adults with epidermolysis bullosa: a cross-sectional study in seven European countries using EQ-5D-5L.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isAuthorOfPublication746ba496-a7de-4696-8a2b-3177544b4b3d
relation.isAuthorOfPublication.latestForDiscovery746ba496-a7de-4696-8a2b-3177544b4b3d
relation.isFunderOfPublicationa418cf3b-f427-4376-a75f-01dba9bb944f
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationb6658f3f-f551-4300-94f3-4c2c5967026f
relation.isFunderOfPublicationfa9033a8-b08f-4af2-80f9-cb96c76322dc
relation.isFunderOfPublication.latestForDiscoverya418cf3b-f427-4376-a75f-01dba9bb944f
relation.isPublisherOfPublicationb35c2080-c7d1-4e7c-95ea-1d4c7d394078
relation.isPublisherOfPublication.latestForDiscoveryb35c2080-c7d1-4e7c-95ea-1d4c7d394078

Files

Original bundle

Now showing 1 - 3 of 3
Loading...
Thumbnail Image
Name:
Health-relatedQualityLifeAdults_2026.pdf
Size:
1.73 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Supplementary_Health-relatedQualityLifeAdults_2026.pdf
Size:
474.94 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
Figure_Health-relatedQualityLifeAdults_2026.webp
Size:
80.34 KB
Format:
WebP is a modern image format that provides superior lossless and lossy compression for images on the web.